Opinion|Videos|August 27, 2024
Choosing MDS Therapies: Risk-Based Approaches
Medical experts discuss risk-based approaches to choosing MDS therapies.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Provide a high level overview of treatment approaches for both lower and higher risk MDS.
- What are the key considerations when selecting between different treatment options for lower risk MDS?
- Please include a discussion of when hypomethylating agents (HMAs) would be used in lower risk disease.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol
2
SYNCHRONIZE-1 Through a Hepatologist's Lens: Liver Fat Reduction, Visceral Fat, and What Comes Next
3
AI Phenotyping Links Cardiovascular, Kidney Disease to Rapid MASH Progression, Higher Costs
4
Stem Cell Transplant Outperforms DMTs in Drug-Resistant Relapsing MS
5